期刊文献+

不同临床表现对糖尿病合并非糖尿病肾病的预测价值 被引量:3

Implications of differentiated clinical manifestations in predicting diabetes mellitus complicated with non-diabetic renal diseases
在线阅读 下载PDF
导出
摘要 目的探讨不同临床表现对糖尿病合并非糖尿病肾病的预测价值。方法疑似糖尿病合并非糖尿病肾病患者73例中糖尿病肾病(diabetic nephropathy,DN)45例、糖尿病合并非糖尿病肾病(non-diabetic renal disease,NDRD)28例,检测患者血肌酐、肾小球滤过率(estimated glomerular filtration rate,eGFR)、24h尿蛋白定量;统计患者临床症状表现(血尿、蛋白尿、高血压、脂代谢紊乱、肾损伤、糖尿病视网膜病变),使用ROC曲线分析评价各指标对于糖尿病合并非糖尿病肾病的预后效果。结果 DN和DNRD患者在性别、年龄、糖尿病病程、血肌酐、肾小球滤过率等方面差异无统计学意义(P>0.05);DN组患者24h尿蛋白定量(3.62±0.96g)低于NDRD组(6.81±2.32 g),差异有统计学意义(P<0.05);2组患者在高血压、脂代谢紊乱、肾损伤方面的差异无统计学意义(P>0.05),在血尿、蛋白尿、糖尿病视网膜病变方面差异有统计学意义(P<0.05)。ROC曲线分析显示,糖尿病病程、是否伴随糖尿病视网膜病变、血尿、24小时尿蛋白量、eGFR均对于NDRD具有一定的预测价值(P<0.05)。结论血尿、是否伴有糖尿病视网膜病变、eGFR对于预测NDRD具有较高的参考价值。 Objective To understand the implications of differentiated clinical manifestations in the prognosis of diabetes mellitus complicated with non-diabetic renal diseases. Methods A total of 45 patients of diabetic nephropathy (DN) and 28 patients of diabetes mellitus combined with non-diabetic renal disease (DNRD) were chosen as the subjects of study. The level of serum creatinine, the estimated glomerular filtration rate (eGFR), and the 24 h urinary protein quantity of the two groups were then detected. The clinical symptoms in terms of hematuria, proteinuria, hypertension, lipid metabolism disorders, kidney damage, and diabetic retinopathy of the two groups were documented. Lastly, ROC curve was utilized for the prognosis of diabetes mellitus combined with DNRD. Results No significant difference was found in sex, age, disease development, serum creatinine and eGFR between the two groups ( P 〉0.05). The 24 h urinary protein quantity of the DN group was 3.62±0.96 g, which was much lower than that of the NDRD group (6.81±2.32 g). The difference was statistically significant ( P 〈0.05). No significant difference was found in hypertension, lipid metabolism and renal injury between the two groups ( P 〉0.05). Significant difference was found in hematuria, proteinuria, and diabetic retinopathy data between the two groups ( P 〉0.05). ROC curve analysis indicated that disease development, hematuria, occurrence of diabetic retinopathy, 24 h urinary protein quantity and eGFR had significant implications in predicting the disease in question. Conclusions Hematuria, diabetic retinopathy, eGFR have significant implications in the prediction of diabetes mellitus combined with DNRD.
作者 杨爱华 张小云 YANG Ai-hua;ZHANG Xiao-yun(Department of Nephrology,The First People's Hospital of Xiaoshan Hangzhou,Hangzhou 311200,China)
出处 《健康研究》 CAS 2018年第4期426-429,共4页 Health Research
关键词 糖尿病肾病 非糖尿病肾病 血尿 糖尿病视网膜病变 肾小球滤过率 diabetic nephropathy non-diabetic renal disease hematuria diabetic retinopathy estimated glomerular filtration rate
  • 相关文献

参考文献11

二级参考文献164

  • 1周建辉,陈香美,谢院生,李建军,吴杰,蔡广研.糖尿病肾病与非糖尿病性肾脏疾病的对比分析及其诊断概率回归方程的建立[J].中华肾脏病杂志,2005,21(4):182-185. 被引量:25
  • 2江中林,姜国良.TGF-β_1在糖尿病肾病早期诊断中的应用[J].放射免疫学杂志,2005,18(3):195-196. 被引量:21
  • 3杨霓芝,刘旭生.糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7-8. 被引量:1221
  • 4Rocco MV, Berns JS. KDOQI Clinical Practice Guideline for Diabetes and CKD : 2012 Update [ J ]. American Journal of Kidney Diseases, 2012, 60 (5): 850-886.
  • 5Jardine MJ, Hata J, Woodward M, et al. Prediction of kidney - relat- ed outeomes in patients with type 2 diabetes [J]. American Journal ot Kidney Diseases, 2012, 60 (5): 770-778.
  • 6Gross JL, De Azevedo MJ, Silveiro SP, et al. Diabetic nephropathy: diagnosis, prevention, and treatment [J] Diabetes Care, 2005, 28 (1): 164 -176.
  • 7American Diabetes Association. Standards of medical care in diabetes - 2009 [J]. Diabetes Care, 2009, 32 (Suppl 1): S13-S61.
  • 8Hilden J, Glasziou P. Regret graphs, diagnostic uncertainty and Youden's Index[J]. Statistics in Medicine, 1996, 15 (10):969- 986.
  • 9Singh SR, Ahmad F, Lal A, et al. Efficacy and safety of insulin ana- logues for the management of diabetes mellitus: a meta - analysis [ J] Canadian Medical Association Journal, 2009, 180 (4) : 385 -397.
  • 10Bed T, Hunsicker LG, Lewis JB, et al. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropa- thy Trial [ J ]. Journal of the American Society of Nephrology, 2005, 16 (7): 2170-2179.

共引文献1932

同被引文献23

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部